New NIH-funded program will train ASU students for the future of AI-powered medicine
PhD student Maitry Trivedi works with Teresa Wu’s team using AI for Alzheimer’s research. Photo illustration by Jeff Newton
The medical sector is increasingly exploring the use of artificial intelligence, or AI, to make health care more affordable and to improve patient outcomes, but new programs are needed to train engineers and biomedical researchers for this future.
A team at Arizona State University has received a $2.35 million award from the National Institutes of Health (NIH) to establish just such a pioneering program to train doctoral students to meet these needs.
The program will welcome its first cohort of PhD students in the spring of 2025.
This new initiative, called Intergenerational Community Driven Training in Alzheimer’s Disease Research: An AI+X Approach, builds on prior successful work by Teresa Wu and Baoxin Li, both professors in the School of Computing and Augmented Intelligence, part of the Ira A. Fulton Schools of Engineering at ASU, to develop AI systems for medical imaging that improve the diagnosis and treatment of Alzheimer's and other neurodegenerative diseases.
AI is perceived as an especially impactful tool for those affected by neurodegenerative diseases since early screening can significantly improve treatment and care options for patients and their families.
“Artificial intelligence will continue to revolutionize health care, changing and improving the way we approach the diagnosis and treatment of many diseases, including Alzheimer's,” Li says. “Successfully preparing researchers for this future is essential.”
Under the new initiative, Wu and Li will join forces with principal investigators Judith Klein-Seetharaman and Ramon Velazquez, researchers in ASU’s Biodesign Institute. Klein-Seetharaman is a leading molecular scientist and professor in ASU's College of Health Solutions and School of Molecular Sciences, while Velazquez is a sought-after expert on the progression of neurodegenerative diseases and an assistant professor in ASU's School of Life Sciences.
Together, the team of researchers will create a curriculum for doctoral students. The new program will combine what students learn in the classroom with what they observe in real-world settings, and then task them with developing new AI tools to help doctors, clinicians and health care workers.
The latest in neuroscience research
The complexity of the human brain allows it to do amazing things, but it also makes it a challenge for medical science to study. Learn more at the Biodesign Institute.
“We are thrilled to bring this opportunity to our doctoral student pool, allowing us to recruit competitive students and immerse them in various training and research activities available at ASU, with the help of our collaborating partners in a necessary area of expertise to improve the lives of those affected with Alzheimer’s disease,” Velazquez says.
Trainees will benefit from the involvement of several local research institutions, including Mayo Clinic, Banner Alzheimer's Institute, Barrow Neurological Institute and Translational Genomics Research Institute (TGen). The program will actively engage the Arizona Alzheimer’s Consortium and the Arizona Alzheimer's Disease Research Center.
One unique aspect of the program is its partnership with Mirabella, a senior living community on the ASU campus, and Hospice of the Valley, Arizona's leading provider of end-of-life care. These collaborations are intended to provide trainees with hands-on experiences that reflect real-life medical challenges and solutions.
As the program prepares to recruit its first cohort, faculty and potential candidates anticipate the transformative impact it will have on the future of Alzheimer’s research.
This initiative not only represents a significant investment in the fight against Alzheimer's disease and related dementias but also highlights ASU’s commitment to innovating through education and collaboration.
More Science and technology
Lucy's lasting legacy: Donald Johanson reflects on the discovery of a lifetime
Fifty years ago, in the dusty hills of Hadar, Ethiopia, a young paleoanthropologist, Donald Johanson, discovered what would become one of the most famous fossil skeletons of our lifetime — the 3.2…
ASU and Deca Technologies selected to lead $100M SHIELD USA project to strengthen U.S. semiconductor packaging capabilities
The National Institute of Standards and Technology — part of the U.S. Department of Commerce — announced today that it plans to award as much as $100 million to Arizona State University and Deca…
From food crops to cancer clinics: Lessons in extermination resistance
Just as crop-devouring insects evolve to resist pesticides, cancer cells can increase their lethality by developing resistance to treatment. In fact, most deaths from cancer are caused by the…